본문 바로가기

Loss of NF2 Induces TGF beta Receptor 1-mediated Noncanonical and Oncogenic TGF beta Signaling: Implication of the Therapeutic Effect of TGF beta Receptor 1 Inhibitor on NF2 Syndrome

Loss of NF2 induces TGFb receptor 1-mediated noncanonical and oncogenic TGFb signaling: Implication of the therapeutic effect of TGFb receptor 1 inhibitor on NF2 syndrome

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
MOLECULAR CANCER THERAPEUTICS17(11) · pp.2271 · 2018
피인용
Web of Science 23Scopus 22
FWCI (Scopus)
0.47
JCR IF
JCR 2017 5.365
ISSN
1535-7163

저자

  1. 조정현제1저자Department of Molecular Biology, College of Natural Science, Pusan National University, Geumjeong-gu, Busan, South Korea
  2. 오아영Department of Molecular Biology, College of Natural Science, Pusan National University, Geumjeong-gu, Busan, South Korea
  3. 박소영Department of Molecular Biology, College of Natural Science, Pusan National University, Geumjeong-gu, Busan, South Korea
  4. 강소미Department of Molecular Biology, College of Natural Science, Pusan National University, Geumjeong-gu, Busan, South Korea
  5. 윤민호Department of Molecular Biology, College of Natural Science, Pusan National University, Geumjeong-gu, Busan, South Korea
  6. 우태균Department of Molecular Biology, College of Natural Science, Pusan National University, Geumjeong-gu, Busan, South Korea
  7. 홍신덕Department of Molecular Biology, College of Natural Science, Pusan National University, Geumjeong-gu, Busan, South Korea
  8. 황지환Department of Microbiology, College of Natural Science, Pusan National University, Busan, South Korea
  9. Ha, Nam-ChulDepartment of Food Engineering, College of Agricultural Science, Seoul National University, Seoul, South Korea
  10. Lee, Ho-YoungDepartment of Nuclear Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea
  11. 박범준교신저자Department of Molecular Biology, College of Natural Science, Pusan National University, Geumjeong-gu, Busan, South Korea

초록

Neurofibromatosis type 2 (NF2) syndrome is a very rare human genetic disease, and there has been no proper treatment for it until now, In our recent study, it has been reported that the loss of NF2 activates MAPK signaling through reduction of RKIP in a mesothelioma model. Here, we show that Loss of NF2 induces reduction of the TGF beta receptor 2 (T beta R2) expression, and an overwhelming expression of TGF beta receptor 1 (T beta R1) is activated by physical stimuli such as pressure or heavy materials. Activated T beta R1 induces the phosphorylation and degradation of RKIP. RKIP reduction consequently results in MAPK activation as well as Snailmediated p53 suppression and occurrence of EMT in NF2-deficient cells by physical stimuli. Thus, T beta R1 kinase inhibitors restore cell differentiation and induce growth suppression in NF2-deficient Schwannoma cell line and MEF. Moreover, TEW7197, a specific T beta R1 kinase inhibitor, reduces tumor formation in the NF2-model mouse (Postn-Cre;NF2(f/f)). Gene expression profiling reveals that TEW7197 treatment induces the expression of lipid metabolism-related gene set, such as NF2-restored cells in HEI-193 (NF2-deficient Schwannoma). Our results indicate that reduction or deletion of T beta R2 or NF2 induces the T beta R1-mediated oncogenic pathway, and therefore inhibition of the unbalanced TGF beta signaling is a putative strategy for NF2-related cancers (NF2 syndrome and mesothelioma) and T beta R2-mutated advanced cancers. (C) 2018 AACR.

키워드

PROSTATE-CANCER CELLSLARGE GENE LISTSNEUROFIBROMATOSIS TYPE-2SCHWANN-CELLSK-RASCHOLESTEROL-BIOSYNTHESISMALIGNANT MESOTHELIOMAOCCUPATIONAL-EXPOSUREP53 SUPPRESSIONPHASE-II

식별자

Scopus EID
2-s2.0-85056025932
WoS UID
000448888000001